Diagnos Inc.
ADK.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 93.20K | 112.90K | 120.70K | 126.10K | 145.40K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 93.20K | 112.90K | 120.70K | 126.10K | 145.40K |
| Cost of Revenue | 728.50K | 698.80K | 678.30K | 747.60K | 698.90K |
| Gross Profit | -635.40K | -586.00K | -557.70K | -621.60K | -553.50K |
| SG&A Expenses | 1.69M | 1.48M | 1.32M | 1.31M | 1.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.42M | 2.18M | 2.00M | 2.06M | 2.05M |
| Operating Income | -2.33M | -2.06M | -1.88M | -1.93M | -1.91M |
| Income Before Tax | -2.74M | -2.47M | -2.28M | -2.31M | -2.25M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.74 | -2.47 | -2.28 | -2.31 | -2.25 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.74M | -2.47M | -2.28M | -2.31M | -2.25M |
| EBIT | -2.33M | -2.06M | -1.88M | -1.93M | -1.91M |
| EBITDA | -2.25M | -1.99M | -1.80M | -1.86M | -1.83M |
| EPS Basic | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 329.01M | 308.25M | 298.16M | 291.36M | 286.46M |
| Average Diluted Shares Outstanding | 329.01M | 308.25M | 298.16M | 291.36M | 286.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
